Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The archive — 2025
Page 13 of 68 of this archive, newest first.
Reproducibility, measured rather than assumed
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
How to check a certificate in ten minutes
What each missing test would cost to add, and which of them a buyer should actually want.
Why receptor selectivity is the least discussed number in incretin pharmacology
The class is described as though every molecule in it did the same thing. At the receptor, they demonstrably do not.
The 8-day notice: how a compounding wind-down works in Singapore
The document is four pages. Three of them are about dates.
The online reseller trading as Adamant Research Supply closes after 23 years
A proper account of an operation that existed, and of what closing it cost.
Sweden health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
QST names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Two sessions a week, and the evidence behind the prescription
Mass and function are different endpoints and training affects them differently. Most coverage treats them as one.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
New Zealand pharmacy body issues counselling standards for semaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Medutest result on a Zhuhai orforglipron lot lands 3.8 points above the supplier’s stated figure
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
TRIUMPH-1 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Percentage of loss, absolute kilograms, and the sleight of hand between them
A substudy powered to describe a mean is not a substudy powered to detect a clinically meaningful individual change.
Randomised withdrawal is the cleanest design in this field and the least discussed
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
What the new Australia guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What changed at SGN in October, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Medutest result on a Qingdao dulaglutide lot lands 1.4 points above the supplier’s stated figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The glucagon receptor arm, and why it is the hardest to reason about
A dual agonist is one molecule with two receptor activities. A co-formulation is two molecules in one pen. The coverage treats them as synonyms.
What a batch number is supposed to mean
What happens to traceability when bulk material is subdivided, repackaged and relabelled two or three times before sale.
The United Arab Emirates pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
Qingdao export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a ERP exenatide lot at 95.8%, against 93.5% on the certificate
A reminder that a purity figure is the output of a method, and that methods differ.
Inspectors cite the relabeller trading as Vantris Bio over sterility assurance
The observation that closes a facility is rarely the dramatic one.
LAL, kinetic chromogenic, recombinant factor C: three ways to the same figure
The masking phenomenon known as low endotoxin recovery means a formulation can return a clean result while containing endotoxin the assay cannot see.
A year after stopping: what the trials found at the far end
The variance around the mean regain trajectory is large and unexplained, exactly as it is for the weight loss.
SUSTAIN-6 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
A supplier suspends shipping to the United Arab Emirates after 15 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.